Formulation and Evaluation of Piperazine Citrate Medicated Candy for Pediatric Drug Delivery

Pediatric drug delivery is a significant challenge in pharmaceutical formulation development because children often experience difficulty swallowing conventional dosage forms such as tablets and capsules. Poor palatability and unpleasant taste may further reduce patient compliance and affect the successful administration of medication. Medicated candy represents a promising alternative dosage form that combines acceptable taste, convenience, and ease of administration. The present review focuses on the formulation and evaluation of Piperazine citrate medicated candy as a potential drug delivery system for pediatric patients. Piperazine citrate is an anthelmintic agent used in the treatment of certain intestinal worm infections. Incorporating this drug into a palatable candy formulation may improve acceptability and encourage better medication compliance among children. The formulation involves the selection of suitable excipients, including sweetening agents, flavouring agents, and a suitable candy base, while maintaining drug stability and uniformity. Various evaluation parameters, such as appearance, weight variation, hardness, moisture content, drug content uniformity, in-vitro drug release, taste acceptability, and stability studies, are important for assessing the quality of the developed formulation. Special attention should be given to dose accuracy, pediatric safety, and appropriate packaging to prevent accidental consumption. This review highlights the potential advantages, formulation considerations, evaluation methods, and challenges associated with Piperazine citrate medicated candy. Overall, this dosage form may offer a patient-friendly approach to pediatric anthelmintic therapy; however, its effectiveness, safety, stability, and suitability require systematic investigation and appropriate pharmaceutical evaluation before clinical use.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-14
DOI
https://doi.org/10.5281/zenodo.24217156
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Formulation and Evaluation of Piperazine Citrate Medicated Candy for Pediatric Drug Delivery

Prajkta Annasaheb Kate, Yash K. Tambe, Dr. Sampat D. Navale
Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical studies and practices
article

Formulation and Evaluation of Piperazine Citrate Medicated Candy for Pediatric Drug Delivery

Prajkta Annasaheb Kate, Yash K. Tambe, Dr. Sampat D. Navale
article en

Abstract

Pediatric drug delivery is a significant challenge in pharmaceutical formulation development because children often experience difficulty swallowing conventional dosage forms such as tablets and capsules. Poor palatability and unpleasant taste may further reduce patient compliance and affect the successful administration of medication. Medicated candy represents a promising alternative dosage form that combines acceptable taste, convenience, and ease of administration. The present review focuses on the formulation and evaluation of Piperazine citrate medicated candy as a potential drug delivery system for pediatric patients. Piperazine citrate is an anthelmintic agent used in the treatment of certain intestinal worm infections. Incorporating this drug into a palatable candy formulation may improve acceptability and encourage better medication compliance among children. The formulation involves the selection of suitable excipients, including sweetening agents, flavouring agents, and a suitable candy base, while maintaining drug stability and uniformity. Various evaluation parameters, such as appearance, weight variation, hardness, moisture content, drug content uniformity, in-vitro drug release, taste acceptability, and stability studies, are important for assessing the quality of the developed formulation. Special attention should be given to dose accuracy, pediatric safety, and appropriate packaging to prevent accidental consumption. This review highlights the potential advantages, formulation considerations, evaluation methods, and challenges associated with Piperazine citrate medicated candy. Overall, this dosage form may offer a patient-friendly approach to pediatric anthelmintic therapy; however, its effectiveness, safety, stability, and suitability require systematic investigation and appropriate pharmaceutical evaluation before clinical use.

Zenodo (CERN European Organization for Nuclear Research)
Dr. Babasaheb Ambedkar Technological University (IN)
Pharmaceutical studies and practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon